Bio基因序列数据库

Bio序列数据库中共包含6.6亿条核苷酸和蛋白质序列数据，1700万条抗体序列，超过173万条人工标注的化学修饰序列数据，1.2亿条序列与专利关联数据，根据其数据公开方式，主要分为三种，专利、文献和其它库，其它库主要包括NCBI和美国化学文摘社（CAS），以最优的算法，一站式检索+分析体验，帮助您轻松完成查新和自由实施（FTO）搜索，帮助降低重复研发成本的同时，降低自由实施和诉讼风险。This bio-sequence database contains a total of 660 million nucleotide and protein sequence records, 17 million antibody sequences, over 1.73 million manually annotated chemically modified sequence datasets, and 120 million sequence-patent linked data. Based on their public disclosure approaches, the database is primarily categorized into three groups: patents, scholarly literature, and other repositories. The other repositories mainly include NCBI and the Chemical Abstracts Service (CAS). Equipped with state-of-the-art algorithms, it delivers a one-stop retrieval and analysis experience, enabling users to easily conduct novelty searches and Freedom to Operate (FTO) searches. This helps reduce redundant R&D costs as well as mitigate Freedom to Operate and litigation risks.

搜集汇总

背景与挑战

背景概述

Bio基因序列数据库包含6.6亿条核苷酸/蛋白质序列、1700万抗体序列及173万化学修饰序列，整合专利文献等多元数据源，提供一站式检索分析服务，可辅助生物医药研发查新和降低专利风险。